14.47500 EUR
0.01
0.07%
Last update Dec 17, 8:16 AM CET
Main market
Day range
14.47500
14.47500
Previous close
14.46500
Open
14.47500
Access this stock data via API
Subscribe
Denali Therapeutics Inc.
14.48
0.01
0.07%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 86.9M 87.5M 99.1M 85.1M
Selling general and admin 30.2M 27.5M 25.0M 25.6M
Other operating expenses
Operating income -117.2M -115.1M -124.1M -110.7M
Non operating interest income
Income 9.0M 9.2M 10.7M 12.9M
Expense
Other income expense 0
Pretax income -108.2M -105.8M -113.4M -97.8M
Tax provision
Net income -108.2M -105.8M -113.4M -97.8M
Basic EPS -0.7 -0.8 -0.7
Diluted EPS -0.7 -0.8 -0.7
Basic average shares 146.2M 146.0M 145.0M
Diluted average shares 146.2M 146.0M 145.0M
EBITDA -113.9M -111.7M -121.4M -108.5M
Net income from continuing op. -108.2M -105.8M -113.4M -97.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 46 minutes

21:13
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).